The Baroreflex in Hypertension

Current Hypertension Reports
Genaro FernandezJohn P Gassler

Abstract

Hypertension is a complex syndrome that increases the risk of developing other medical comorbidities and interacts with other medical conditions to increase the risk of target end-organ damage such as cardiovascular disease, stroke, and renal disease. Hypertension remains under-recognized and poorly controlled in the USA and worldwide. In some patients, hypertension is resistant to optimal medical therapy. Over the last few decades, there has been an increasing understanding of the role of the sympathetic nervous system in the development and maintenance of hypertension. This update reviews the physiology and role of the sympathetic nervous system in hypertension and pharmacological and interventional treatments directed at nervous system involvement in secondary hypertension.

References

Mar 1, 1986·Journal of Applied Physiology·V S BishopC Hamm
Jul 1, 1967·American Journal of Surgery·S I SchwartzN Hagfors
Jul 1, 1996·Trends in Pharmacological Sciences·A P NicholasV A Pieribone
Aug 19, 1999·The New England Journal of Medicine·R W Schrier, W T Abraham
May 7, 2002·American Journal of Hypertension·James OuzanMichel Mertes
May 23, 2002·Hypertension·Sandra J TalerJo Ellen Augustine
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Aug 15, 1953·Journal of the American Medical Association·R H SMITHWICK, J E THOMPSON
Mar 1, 1956·Circulation Research·J W MCCUBBINI H PAGE
Oct 24, 2003·American Journal of Hypertension·Mari Konishi NishizakaDavid A Calhoun
Mar 10, 2009·Autonomic Neuroscience : Basic & Clinical·James P FisherPaul J Fadel
Aug 28, 2009·The New England Journal of Medicine·Markus P SchlaichMurray D Esler
Dec 4, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Gerald F DiBona, Murray Esler
Oct 5, 2010·Journal of the American College of Cardiology·Ingrid J M ScheffersPeter W de Leeuw
Sep 3, 2011·Cardiovascular Therapeutics·Lincoln P EdwardsPaul Ernsberger
Feb 27, 2013·Hypertension·Robert M Carey
Aug 3, 2013·Current Vascular Pharmacology·Dragan LovicBranko Jakovljevic
Apr 1, 2014·The New England Journal of Medicine·Deepak L BhattUNKNOWN SYMPLICITY HTN-3 Investigators

❮ Previous
Next ❯

Citations

Jan 27, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Yu-Ping ZhangBaojian Xue
May 22, 2018·Journal of Hypertension·Giris JacobRaffaello Furlan
May 18, 2019·Cardiovascular Toxicology·Thatiany Jardim BatistaKarla Nívea Sampaio
Jun 3, 2020·The Journal of Clinical Investigation·Huan-Jun LuUhtaek Oh
Sep 26, 2020·Frontiers in Physiology·Ana Rosa BeltránDavid C Andrade
Mar 14, 2019·Computational and Mathematical Methods in Medicine·Agnieszka KazimierskaMagdalena Kasprowicz
Oct 14, 2021·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Anna TaboniGuido Ferretti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.